Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: In vitro and in vivo studies

Urological Research

Volumn 27, Issue 6, 1999, Pages 437-444

  Kim, S C ^a   Seo, K K ^a   Lee, S K ^a   Song, E S ^a   Lee, M Y ^b  

^a Chung Ang University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Cavernous smooth muscle; Erectile dysfunction; Intracavernosal injection; Phentolamine; Tamsulosin

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; TAMSULOSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOG; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE CONTRACTILITY;

EID: 0033403184     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050133     Document Type: Article

References (29)

1. Aboseif S, Riemer RK, Stackl W, Lue TF, Tanagho EA (1993) Quantification of prostaglandin El receptors in cavernous tissue of men, monkeys and dogs. Urol Int 50:148
2. Andersson KE, Wagner G (1995) Physiology of penile erection. Physiol Rev 75:191
3. Andersson KE, Lepor H, Wyllie MG (1997) Prostatic α1-adrenoceptors and uroselectivity. Prostate 30:205
4. Barada JH, McKimmy RM (1994) Vasoactive pharmacotherapy. In: Bennett AH (ed) Impotence. Saunders, Philadelphia, pp 229-250
5. Becker AJ, Stief CG, Machtens S, Schultheiss D, Hartmann U, Truss MC, Jonas U (1998) Oral phentolamine as treatment for erectile dysfunction. J Urol 159:1214
6. 1-adrenergic antagonists in the prostate. J Urol 149:395
7. Cahn D, Melman A, Valcic M, Christ GJ (1996) Forskolin: A promising new adjunct to intracavernous pharmacotherapy. J Urol 155:1789
8. Chen J, Godschalk MF, Katz PG, Mulligan T (1995) Combining intracavernous injection and external vacuum as treatment for erectile dysfunction. J Urol 153:1476
9. Delafflotte S, Auguet M, Chabrier PE (1996) Pharmacological evidence that different alpha 1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery. Acta Physiol Scand 158:241
10. Dinsmore WW, Alderdice DK, German M (1997) Vasoactive intestinal polypeptide and phentolamine mesylate by autoinjection in pharmaco resistant erectile dysfunction. Int J Impotence Res 9 (suppl 1):S27
11. Fallon B (1995) Intracavernous injection therapy for male erectile dysfunction. Urol Clin N Am 22:833
12. Gerstenberg TC, Metz P, Ottesen B, Fahrenkrug J (1992) Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure. J Urol 147:1277
13. Gupta S, Moreland RB, Yang S, Gallant CM, Golstein I, Traish AM (1998) The expression of functional postsynaptic α2-adrenoceptors in the corpus cavernosum smooth muscle. Br J Pharmacol 123:1237
14. Hatano A, Takahashi H, Tamaki M, Komeyama M, Koizumu T, Takeda M (1994) Pharmacological evidence of distinct α1 adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Pharmacol Commun 5:117
15. Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE (1998) Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology 52:739
16. 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology 44:52
17. 1-induced penile erection in rabbits. Eur Urol 28:265
18. McMahon CG (1991) A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1, and a combination of all three agents in the management of impotence. Int J Impotence Res 3:113
19. Michel MC, Mehlburger L, Bressel HU, Schumacher H, Schafers RF, Goepel M (1998) Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms does co-morbidity alter tolerability? J Urol 160:784
20. Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I (1997) Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol 158:1752
21. Padma-Nathan H (1997) Minimally invasive therapy for erectile dysfunction: intracavernosal, oral, transdermal/transglanular, and intraurethral approaches. In: Mulcahy JJ (ed). Diagnosis and management of male sexual dysfunction. Igaku-Shoin, New York, pp 182-195
22. Price DT, Schwinn DA, Lomasney JW, Allen LF, Caron MG, Lefkowitz RJ (1993) Identification, quantification, and localization of mRNA for the distinct alpha 1 adrenergic receptor subtypes in human prostate. J Urol 150:546
23. Ruffolo Jr RR, Nichols AJ, Stadel JM, Hieble JP (1991). Structure and function of α-adrenoceptors. Pharmacol Rev 43:475
24. Seo KK, Bang JH, Kim SC (1997) Penile erection induced by TM sterile powder in dogs: comparison with bimix, papaverine, and PGE1. J Kor Androl Soc 15:97
25. Seo KK, Lee MY, Lim SW, Kim SC (1999) Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha 1-adrenoceptor antagonists: prazosin, terazosin, doxazosin, and tamsulosin. J Kor Med Sci 14:69
26. Torres-Marquez ME, Villalobos-Molina R, Garcia-Sainz JA (1991 ) Alpha 1-adrenoceptor subtypes in aorta (alpha 1A) and liver (alpha 1B). Eur J Pharmacol 206:199
27. Traish AM, Gupta S, Toselli P, Saenz de Tejada I, Goldstein I, Moreland RB (1995) Identification of alpha-1 adrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptor 5:145
28. Traish M, Moreland RB, Huang Y, Gupta S, Goldstein I (1996) Functional α2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells. Int J Impotence Res 8:A34
29. 1-antagonists. Life Sci 54:1845